Time spent on ineffective treatments is time that could be spent on evidence-based options with demonstrated outcomes
For a juice guy to take fruits, make juice and then ferment it, its like I made a mistake, Langer said
MeAgain is a tracking and education app, not a clinical service clinical decisions stay with your licensed clinician
Snapshot of the 2026 Speaker Faculty Top Takeaways: Unlocked the next generation of GLP-1 combinations and gained competitive intelligence on multi-agonist and combination therapies designed to enhance efficacy, minimize muscle loss, and improve body composition for superior patient outcomes Discovered high-value indication expansion and explored the next frontier of GLP-1 development beyond obesity through exclusive data on clinical programs targeting liver, renal and cardiometabolic disorders alongside neurological diseases and womens health conditions Mastered alternative delivery and patient adherence through dedicated sessions focused on overcoming the challenges of administration through oral programs and less frequent dosing strategies for long-term patient success Benchmarked against industry titans and innovators and heard directly from the companies leading the pipeline, including experts from Eli Lilly , Constructive Bio and Regeneron
On iOS and Android, with about a 3 day trial, then around $3.99/wk, $9.99/mo, or $39.99/yr
FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or any other pharmaceutical manufacturer mentioned in this article
